In breast cancer, gene expression profiling has revealed four main intrinsic molecular subtypes that show apparent differences in the gene expression patterns: luminal A, luminal B, triple-negative, and human epidermal growth factor receptor 2(HER2)-enriched. Here, ERBB2 is linked to breast cancer.